Accordingly, α-SMA levels and tumor-promoting capacity of BM-MSCs enhanced by CD44-enriched AGS-sEV were obviously eliminated by U0126 and GW9662 (Fig. 5l–o, Additional file 9: Fig. S5A–F). This evidence concerns the gene CD44 and neoplasm.